Streetbeat News

Products Services

AHOY

Newday Impact has launched AHOY 2.0, an ETF focused on ocean health. This ETF aims to invest in companies contributing positively to the health of the world's oceans, addressing issues like pollution and overfishing.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 1:38 pm

CHTR

DIS

Charter Communications, Inc (NASDAQ:CHTR) reported a slight revenue growth in Q4 FY23 but missed EPS estimates, leading to a stock price drop. The company saw growth in Internet and Mobile services but lost residential Internet and video customers, partly due to a temporary loss of Walt Disney Company (NYSE:DIS) programming. Despite higher capital expenditures for network expansion, Charter expects increased Capex in 2024. CHTR shares fell 9.24% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

February 02, 2024 | 1:33 pm

SIDU

Sidus Space, Inc. (SIDU) has announced its membership in the Solis Applied Science, LLC team, which was selected by the National Geospatial-Intelligence Agency (NGA) to provide research and development services to NGA's Research and Development Directorate. This collaboration highlights Sidus Space's involvement in significant government contracts and its role in advancing geospatial intelligence and research.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 1:31 pm

CALC

FGEN

ORMP

PEPG

Four health care stocks, PepGen Inc. (PEPG), CalciMedica, Inc. (CALC), Oramed Pharmaceuticals Inc. (ORMP), and FibroGen, Inc. (FGEN), are considered overbought as of Feb. 2, 2024, based on their RSI values. Recent developments and price actions for each company are highlighted, with PEPG and FGEN showing significant gains, while CALC and ORMP experienced declines.

Portfolio Pulse from Avi Kapoor

February 02, 2024 | 1:21 pm

AZTA

Azenta, Inc. has announced the launch of BioArc Ultra, a new product in their portfolio. This launch could signify an expansion in Azenta's offerings and potentially increase its market share in the biotechnology sector.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 1:15 pm

AAPL

The iPhone 15 Pro, a premium variant of Apple Inc.'s latest smartphone series, is facing lower customer satisfaction ratings despite its advanced features. Issues such as overheating, battery life, minor upgrades, and design concerns have been highlighted. This contrasts with CEO Tim Cook's claim of a 99% satisfaction rate for the iPhone 15 series, which also reported a 6% sales increase over the iPhone 14 series and helped Apple secure a 64% US market share in Q4 2023.

Portfolio Pulse from Rounak Jain

February 02, 2024 | 12:45 pm

ABBV

AbbVie has updated its sales outlook, projecting combined sales for Skyrizi and Rinvoq to exceed $27 billion by 2027. Additionally, the company has raised its peak sales forecast for Ubrelvy and Qulipta, expecting them to collectively surpass $3 billion.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 12:41 pm

JFBR

Jeffs' Brands announced that its unit, Fort Products, has secured an exclusive distribution agreement for solar panel protection. This agreement positions Jeffs' Brands (JFBR) to potentially increase its market share in the renewable energy sector.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 12:37 pm

NVAX

Novavax announced the publication of Phase 3 trial results for its R21/Matrix-M malaria vaccine in The Lancet, reporting a 75% efficacy when administered before the high transmission season in areas with highly seasonal malaria transmission.

Portfolio Pulse from Charles Gross

February 02, 2024 | 12:11 pm

PLUG

Plug Power announced it has signed a BEDP contract for a 500MW electrolyzer project in Europe, marking a significant expansion in its hydrogen production capabilities.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 12:10 pm